Proteome selectivity profiling of photoaffinity probes derived from imidazopyrazine-kinase inhibitors
Abstract Kinases are attractive drug targets, but the design of highly selective kinase inhibitors remains challenging. Selectivity may be evaluated against a panel of kinases, or – preferred – in a complex proteome. Probes that allow photoaffinity-labeling of their targets can facilitate this proce...
Saved in:
Main Authors: | Dimitris Korovesis, Christel Mérillat, Rita Derua, Steven H. L. Verhelst |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Communications Chemistry |
Online Access: | https://doi.org/10.1038/s42004-025-01436-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
by: Tommaso Porcelli, et al.
Published: (2025-02-01) -
Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing
by: Margeaux Hodgson-Garms, et al.
Published: (2025-02-01) -
FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury
by: Dezhu Gao, et al.
Published: (2024-12-01) -
PROTEOMIC PROFILING OF BLOOD-BASED BIOMARKERS IN THE EARLY DETECTION OF ALZHEIMERS DISEASE
by: Syeda Uroosa Hashmi, et al.
Published: (2024-06-01) -
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia
by: Benjamin M. Heyman, et al.
Published: (2025-02-01)